BACKGROUND
Ulcerative
colitis (UC) is a chronic inflammatory intestinal disease, and its morbidity is rising worldwide. Previous study indicated that
astragaloside II (AS II), a monomeric compound, was used to treat bowel disease. However, the effects of AS II on UC remains